Millennium Management
PRDS

Millennium Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Millennium Management’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-343,595
Closed -$622K – 6796
2023
Q2 		$622K Buy
343,595
+202,554
+144% +$370K ﹤0.01% 4391
2023
Q1 		$186K Buy
141,041
+91,032
+182% +$149K ﹤0.01% 5202
2022
Q4 		$85K Buy
50,009
+9,228
+23% +$11.7K ﹤0.01% 5633
2022
Q3 		$75K Sell
40,781
-40,046
-50% -$119K ﹤0.01% 6062
2022
Q2 		$248K Sell
80,827
-164,341
-67% -$1M ﹤0.01% 5516
2022
Q1 		$1.77M Buy
245,168
+10,770
+5% +$106K ﹤0.01% 4003
2021
Q4 		$3.84M Sell
234,398
-277,485
-54% -$3.23M ﹤0.01% 3163
2021
Q3 		$5.09M Sell
511,883
-10,620
-2% -$106K ﹤0.01% 2836
2021
Q2 		$5.21M Buy
522,503
+47,503
+10% +$477K ﹤0.01% 2698
2021
Q1 		$4.73M Buy
+475,000
New +$4.91M ﹤0.01% 2627

Other funds holding PRDS

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Millennium Management's PRDS Position: Q3 2023 in Review

Millennium Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 343,595 shares — an estimated $622K sold.

Millennium Management first reported a position in PRDS in Q1 2021 and held it in 10 quarters. The position peaked at $5.21M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

  • Millennium Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 343,595 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $622K.
  • Millennium Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Millennium Management's Pardes Biosciences, Inc. Common Stock position peaked at $5.21M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.